Weitzenkamp, D. A., Gerhart, K. A., Charlifue, S. W., Whiteneck, G. G., & Savic, G. (1997). Spouses of spinal cord injury survivors: The added impact of caregiving. Archives of Physical Medicine and Rehabilitation, 78(8), 822–827. https://doi.org/10.1016/S0003-9993(97)90194-5

Article  CAS  PubMed  Google Scholar 

Rees, J., O’boyle, C., & MacDonagh, R. (2001). Quality of life: Impact of chronic illness on the partner. Journal of the Royal Society of Medicine, 94(11), 563–566. https://doi.org/10.1177/014107680109401103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pinto, R. A., Holanda, M. A., Medeiros, M. M., Mota, R. M., & Pereira, E. D. (2007). Assessment of the burden of caregiving for patients with chronic obstructive pulmonary disease. Respiratory Medicine, 101(11), 2402–2408. https://doi.org/10.1016/j.rmed.2007.06.001

Article  PubMed  Google Scholar 

das Medeiros, C., Ferraz, M. M., M. B., & Quaresma, M. R. (2000). The effect of rheumatoid arthritis on the quality of life of primary caregivers. The Journal of Rheumatology, 27(1), 76–83.

Google Scholar 

Rivera-Navarro, J., Benito-León, J., Oreja-Guevara, C., Pardo, J., Bowakim Dib, W.,Orts, E., … Caregiver Quality of Life in Multiple Sclerosis (CAREQOL-MS) Study Group.(2009). Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis. Multiple Sclerosis Journal, 15(11), 1347–1355. doi:10.1177/1352458509345917.

Belasco, A. G., & Sesso, R. (2002). Burden and quality of life of caregivers for hemodialysis patients. American Journal of Kidney Diseases, 39(4), 805–812. https://doi.org/10.1053/ajkd.2002.32001

Article  PubMed  Google Scholar 

Malliori, M. M., Chioti, V., & Konstantopoulou, K. (2010). Extra care burden in comorbid mental–somatic illnesses. Current Opinion in Psychiatry, 23(4), 373–377. https://doi.org/10.1097/YCO.0b013e328338c1b2

Article  PubMed  Google Scholar 

Basra, M. K. A., & Finlay, A. Y. (2007). The family impact of skin diseases: The Greater patient concept. British Journal of Dermatology, 156(5), 929–937. https://doi.org/10.1111/j.1365-2133.2007.07794.x

Article  CAS  PubMed  Google Scholar 

Shah, R., Ali, F. M., Finlay, A. Y., & Salek, M. S. (2021). Family reported outcomes, an unmet need in the management of a patient’s disease: Appraisal of the literature. Health and Quality of life Outcomes, 19, 1–35. https://doi.org/10.1186/s12955-021-01819-4

Article  Google Scholar 

Aoun, S. M., Grande, G., Howting, D., Deas, K., Toye, C., Troeung, L., … Ewing, G.(2015). The impact of the carer support needs assessment tool (CSNAT) in community palliative care using a stepped wedge cluster trial. PloS one, 10(4), e0123012. doi:10.1371/journal.pone.0123012.

Wood, R., Taylor-Stokes, G., Lees, M., & Chirita, O. (2017). Cost burden associated with advanced non-small cell lung Cancer (A-NSCLC): Impact of disease stage. Value in Health, 20(9), A427. https://doi.org/10.1016/j.jval.2017.08.170

Article  Google Scholar 

Porter, M. E., & Lee, T. H. (2013). The strategy that will fix health care. Harv Bus Rev, 91(10), 50–70. https://hbr.org/2013/10/the-strategy-that-will-fix-health-care

Google Scholar 

Teisberg, E., Wallace, S., & O’Hara, S. (2020). Defining and implementing value-based health care: A strategic framework. Academic Medicine, 95(5), 682–685. https://doi.org/10.1097/ACM.0000000000003122

Article  PubMed  Google Scholar 

Lehtonen, L., Wild, C., Ricciardi, W., Barros, P. P., Brouwer, W., De Maeseneer, J.,… Siciliani, L. (2019). Defining Value in Value-Based Healthcare: Report of the Expert Panel on effective ways of investing in Health (EXPH). doi:10.2875/35471.

European Union (2001). Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. https://www.legislation.gov.uk/eudr/2001/83/contents#

European Union (2007). Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on Advanced Therapy Medicinal Products and Amending Directive 2001/83/EC and Regulation (EC) No 726/2004. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02007R1394-20190726

Iglesias-López, C., Agustí, A., Obach, M., & Vallano, A. (2019). Regulatory framework for advanced therapy medicinal products in Europe and United States. Frontiers in Pharmacology, 10, 471441. https://doi.org/10.3389/fphar.2019.00921

Article  CAS  Google Scholar 

Goula, A., Gkioka, V., Michalopoulos, E., Katsimpoulas, M., Noutsias, M., Sarri, E.F., … Kostakis, A. (2020). Advanced therapy medicinal products challenges and perspectives in regenerative medicine. Journal of Clinical Medicine Research, 12(12), 780. doi:10.14740/jocmr3964.

Magrelli, F. M., Merra, A., & Pellegrini, G. (2020). Surgery versus ATMPs: An example from ophthalmology. Frontiers in Bioengineering and Biotechnology, 8, 440. https://doi.org/10.3389/fbioe.2020.00440

Article  PubMed  PubMed Central  Google Scholar 

Hanna, E., Toumi, M., Dussart, C., Borissov, B., Dabbous, O., Badora, K., & Auquier, P. (2018). Funding breakthrough therapies: A systematic review and recommendation. Health Policy, 122(3), 217–229. https://doi.org/10.1016/j.healthpol.2017.11.012

Article  CAS  PubMed  Google Scholar 

Angelis, A., Lange, A., & Kanavos, P. (2018). Using health technology assessment to assess the value of new medicines: Results of a systematic review and expert consultation across eight European countries. The European Journal of Health Economics, 19, 123–152. https://doi.org/10.1007/s10198-017-0871-0

Article  PubMed  Google Scholar 

Gonçalves, E. (2020). Advanced therapy medicinal products: Value judgement and ethical evaluation in health technology assessment. The European Journal of Health Economics, 21(3), 311–320. https://doi.org/10.1007/s10198-019-01147-x

Article  PubMed  PubMed Central  Google Scholar 

Gonçalves, E. (2022). Value-based pricing for advanced therapy medicinal products: Emerging affordability solutions. The European Journal of Health Economics, 23(2), 155–163. https://doi.org/10.1007/s10198-021-01276-2

Article  PubMed  Google Scholar 

Jones, G. (2018). Raising the profile of pilot and feasibility studies in relation to the development, evaluation and implementation of patient-reported outcome measures. Pilot and Feasibility Studies, 4, 1–4. https://doi.org/10.1186/s40814-017-0151-x

Article  Google Scholar 

Golics, C. J., Basra, M. K. A., Finlay, A. Y., & Salek, S. (2014). The development and validation of the family reported Outcome measure (FROM-16)© to assess the impact of disease on the partner or family member. Quality of Life Research, 23, 317–326. https://doi.org/10.1007/s11136-013-0457-y

Article  PubMed  Google Scholar 

Shah, R., Finlay, A. Y., Salek, M. S., Allen, H., Nixon, S. J., Nixon, M., … Ingram,J. R. (2024). Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16). Journal of Patient-Reported Outcomes, 8(1), 38. doi.org/10.1186/s41687-024-00703-1.

Shah, R., Finlay, A. Y., Salek, S. M., Nixon, S. J., Otwombe, K., Ali, F. M., & Ingram, J. R. (2023). Meaning of Family reported Outcome measure (FROM-16) severity score bands: A cross-sectional online study in the UK. British Medical Journal Open, 13(3), e066168. https://doi.org/10.1136/bmjopen-2022-066168

Article  Google Scholar 

Shah, R., Salek, M. S., Finlay, A. Y., Kay, R., Nixon, S. J., Otwombe, K., … Ingram,J. R. (2024). Mapping of family reported outcome measure (FROM-16) scores to EQ-5D:algorithm to calculate utility values. Quality of Life Research, 33(4), 1107–1119. doi: 10.1007/s11136-023-03590-z.

Golics, C. J., Basra, M. K. A., Salek, M. S., & Finlay, A. Y. (2013). The impact of patients’ chronic disease on family quality of life: An experience from 26 specialties. International Journal of General Medicine, 787–798. https://doi.org/10.2147/IJGM.S45156

Chantarasap, P., Johns, N. P., Pairojkul, S., Sookprasert, A., Wirasorn, K., Cheawchanwattana,A., … Subongkot, S. (2019). Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer. Health and Quality of Life Outcomes, 17, 1–8. doi:10.1186/s12955-019-1091-3.

Elsner, S. A., Salek, S. S., Finlay, A. Y., Hagemeier, A., Bottomley, C. J., Katalinic, A., & Waldmann, A. (2021). Validation of the German version of the family reported outcome measure (FROM-16) to assess the impact of disease on the partner or family member. Health and Quality of Life Outcomes, 19, 1–14. https://doi.org/10.1007/s11136-013-0457-y

Article  Google Scholar 

Oh, H. Y., & Shin, Y. S. (2021). Psychometric properties of the Korean family reported outcome measure for family members of patients with acquired brain injury. Journal of Neuroscience Nursing, 53(6), 256–261. https://doi.org/10.1097/JNN.0000000000000619

Article  Google Scholar 

Wójcik, E., Reszke, R., Otlewska, A., Matusiak, Ł., FINLAY, A. Y., & SZEPIETOWSKI, J. C. (2020). Family reported Outcome Measure–16 (FROM-16): Creation, reliability and reproducibility of the Polish Language Version. Acta Dermato-Venereologica, 100(14). https://doi.org/10.2340/00015555-3583

Shah, R., Ali, F. M., Nixon, S. J., Ingram, J. R., Salek, S. M., & Finlay, A. Y. (2021). Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: A cross-sectional international online survey. BMJ open, 11(5), e047680. https://doi.org/10.1136/bmjopen-2020-047680

Article  PubMed  PubMed Central  Google Scholar 

Brittain, E., Muirhead, N., Finlay, A. Y., & Vyas, J. (2021). Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS): Major impact on lives of both patients and family members. Medicina, 57(1), 43. https://doi.org/10.3390/medicina57010043

Article  PubMed  PubMed Central  Google Scholar 

Raja, A., Wood, F., & Joshi, H. B. (2020). The impact of urinary stone disease and their treatment on patients’ quality of life: A qualitative study. Urolithiasis, 48, 227–234. https://doi.org/10.1007/s00240-019-01142-0

Article  PubMed  Google Scholar 

Davies, R., & Dart, J. (2005). The ‘most significant change’(MSC) technique. A Guide to its use, 10. https://doi.org/10.13140/RG.2.1.4305.3606

QSR International Pty Ltd (2020). NVivo (released in March 2020).

R Core Team. (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing.

Gamer, M., Lemon, J., Fellows, I., & Singh, P. (2019). irr: Various coefficients of interrater reliability and agreement. R package version 0.84. 1. Computer Software and Manual]. Retrieved from. https://cran.r-project.org/package=irr

Rizopoulos, D. (2007). Ltm: An R package for latent variable modeling and item response analysis. Journal of Statistical Software, 17, 1–25. https://doi.org/10.18637/jss.v017.i05

Article  Google Scholar 

IBM Corp (2021). IBM SPSS Statistics for Windows, Version 28.0. Published online 2021.

Shah, R., Finlay, A. Y., Salek, S. M., Nixon, S. J., Otwombe, K., Ali, F. M., & Ingram, J. R. (2023). Meaning of Family reported Outcome measure (FROM-16) severity score bands: A cross-sectional online study in the UK. BMJ open, 13(3), e066168. https://doi.org/10.1136/bmjopen-2022-066168

Article  PubMed  PubMed Central  Google Scholar 

Chantarasap, P., Johns, N. P., Pairojkul, S., Sookprasert, A., Wirasorn, K., Cheawchanwattana,A., … Subongkot, S. (2019). Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer. Health and Quality of Life Outcomes, 17, 1–8. doi.org/1